Stock futures rise on news of upcoming U.S.-China trade talks: Live updates

Stock futures rise on news of upcoming U.S.-China trade talks: Live updates


Traders work on the floor of the New York Stock Exchange on April 29, 2025.

NYSE

Stock futures advanced Tuesday night as investors monitored the latest updates on U.S. trade negotiations and looked toward the Federal Reserve interest rate announcement expected Wednesday afternoon.

Dow Jones Industrial Average futures added 236 points, or 0.6%. S&P 500 futures popped 0.7%, while Nasdaq 100 futures rallied 0.8%.

Stock futures took a leg up after government spokespeople said U.S. Treasury Secretary Scott Bessent and top trade official Jamieson Greer would meet with their Chinese counterparts this week in Switzerland. That can be taken as a positive sign for developments on trade negotiations after turbulent market action following President Donald Trump’s tariff announcement last month.

That action comes as investors gear up for the Fed’s interest rate decision slated for 2 p.m. ET. Fed funds futures are pricing in a nearly 97% likelihood that the central bank holds the borrowing rate steady, according to CME’s FedWatch tool.

Traders will closely monitor Fed Chair Jerome Powell’s post-decision press conference for insights into the path of rates and state of the economy. It comes at a precarious moment for the central bank leader after being the target of criticism from Trump, who has said his “termination cannot come fast enough.” At one point, White House economic advisor Kevin Hassett said the team would “study” whether Powell could be fired, though Trump later said he has “no intention” of removing the Fed chief.

The Fed meeting also comes as market participants contend with concerns that Trump’s plan for levies could push inflation higher, complicating the central bank’s plan for interest rates. Recent turbulence in financial markets and growing fears of the U.S. economy tipping into a recession have heightened worries for investors.

“If traders wish to believe that the Fed will come to the rescue of the world tomorrow and assuage the recent rise in policy uncertainty and political uncertainty with a signal of overt ‘dovishness’, they should think again,” said Thierry Wizman, global foreign exchange and rates strategist at Macquarie.

Market participants also followed the latest batch of corporate earnings. Advanced Micro Devices jumped nearly 5% on a stronger-than-expected earnings report, while Rivian ticked nearly 2% lower after the electric vehicle maker slashed its 2025 delivery target.

Traders will also follow consumer credit data due on Wednesday. Elsewhere, they’ll analyze corporate earnings reports expected from firms including Disney, Carvana and Uber.

Tuesday night’s moves follow a losing day on Wall Street. The Dow lost nearly 390 points, or 1%. The S&P 500 and Nasdaq Composite slid about 0.8% and 0.9%, respectively.



Source

H-1B visa applicants face more disruptions amid social media checks and wage protection rules
World

H-1B visa applicants face more disruptions amid social media checks and wage protection rules

H-1B applicants face a challenging year ahead as political pushback to the visas is reinforced with a slew of actions from the U.S. administration. On Monday, the U.S. Embassy in India posted on X that since Dec. 15, it has started conducting online presence reviews of all H-1B and H-4 visa applicants in a bid […]

Read More
What a Russia-Ukraine peace deal could mean for Europe’s gas supplies
World

What a Russia-Ukraine peace deal could mean for Europe’s gas supplies

Europe is pressing ahead with plans to ban Russian gas imports by the end of 2027, effectively capping Moscow’s energy future in the region and leaving a bevy of stranded assets in its wake. The dual Nord Stream 1 and 2 subsea pipelines were early casualties of Russia’s invasion of Ukraine, with the infrastructure being […]

Read More
Shares in Wegovy-maker Novo Nordisk pop 6% after GLP-1 pill approval
World

Shares in Wegovy-maker Novo Nordisk pop 6% after GLP-1 pill approval

Shares in Novo Nordisk surged 6% Monday, after the Wegovy maker secured approval of its GLP-1 pill — a world first. The U.S. Food and Drug Administration’s approval of Novo Nordisk’s GLP-1 pill gives the Danish pharmaceutical giant a head start over U.S. rival Eli Lilly. The pill’s starting dose of 1.5 milligrams will be […]

Read More